Skip to content

Smoking topography, nicotine kinetics and subjective smoking experience with menthol-containing HTP products of the IQOS brand

Smoking topography, nicotine kinetics and subjective smoking experience with menthol-containing HTP products of the IQOS brand - Nicotide Menthol

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028817
Enrollment
15
Registered
2022-07-26
Start date
2022-07-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F17.2

Interventions

Group 1: Intervention group 1/3: mentholated Heated Tobacco Products of the brand "IQOS Heets Torquoise": Here, according to the study protocol, a CO measurement of the expirium is performed before t

Sponsors

LMU Klinikum München - Klinik für Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: a. Respondent between 18 and 55 years of age b. Lifetime smoker (=100 cigarettes in a lifetime). c. Self-declared occasional smoker (at least one cigarette within the past 30 days and at least one cigarette every 30 days) d. At least 12 hours of smoking abstinence before the start of the test. e. Nicotine plasma concentration to baseline < 10ng/ml. f. Capacity to consent

Exclusion criteria

Exclusion criteria: a. Subjects under 18 or over 55 years of age b. Tobacco dependence according to ICD-10 / FTND>1 i. Daily cigarette consumption ii. Frequent regular use of other nicotine products c. Existing pregnancy i. For contraceptive methods with Pearl index > 0.9, a negative SST must be present prior to initiation of testing d. Pre-existing psychiatric conditions i. Acute suicidality ii. Acute psychiatric illness as defined by ICD-10. iii. Drug, medication, alcohol abuse at the time of the study e. Pre-existing internal medical conditions i. Respiratory insufficiency (e.g., asthma, COPD). ii. Malignant cancer in the past 5 years iii. Severe pre-existing cardiovascular disease and risk factors. 1. manifest arterial hypertension 2. history of myocardial infarction 3. heart failure 4. diabetes mellitus iv. Severe active infectious diseases (Hepatitis. HIV). f. CO > 5ppm in the expirium g. Other circumstances that, in the opinion of the investigator, militate against participation in the study

Design outcomes

Primary

MeasureTime frame
Assessment of changes in smoking behavior, subjective smoking experience, and side effects with use of mentholated HTP compared with nonmentholated HTP and conventional smoking tobacco.

Secondary

MeasureTime frame
Assessment of nicotine kinetics in the acute phase, as well as changes in cardiovascular parameters during the consumption of mentholated HTP compared to non-mentholated HTP and conventional smoking tobacco.

Countries

Germany

Contacts

Public ContactAndrea Rabenstein

LMU Klinikum München - Klinik für Psychiatrie und Psychotherapie

Andrea.Rabenstein@med.uni-muenchen.de089440055539

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026